Profile picture

Ms Emily Ghanbari

German Heart Centre Berlin, Berlin (Germany)
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

Uromodulin as a genetically anchored biomarker stratifies time to valve intervention in aortic regurgitation
Presentation
Uromodulin as a genetically anchored biomarker stratifies time to valve intervention in aortic regurgitation
See more
Polygenic risk stratifies atrial fibrillation into biologically distinct prognostic phenotypes
Presentation
Polygenic risk stratifies atrial fibrillation into biologically distinct prognostic phenotypes
See more
Cardiac amyloidosis exhibits a distinct PAR2-linked transcriptional program
Presentation
Cardiac amyloidosis exhibits a distinct PAR2-linked transcriptional program
See more
PAR2 genetic variation stratifies biomarker dynamics and rehospitalisation risk after acute heart failure
Presentation
PAR2 genetic variation stratifies biomarker dynamics and rehospitalisation risk after acute heart failure
See more
Monocyte F2RL1 signaling defines an adverse remodeling phenotype in heart failure
Presentation
Monocyte F2RL1 signaling defines an adverse remodeling phenotype in heart failure
See more
Investigating the role of protease-activated receptor 2 in adverse cardiac remodeling and clinical outcomes in heart failure: insights from translational research
Presentation
Investigating the role of protease-activated receptor 2 in adverse cardiac remodeling and clinical outcomes in heart failure: insights from translational research
See more
Genotype-dependent NT-proBNP, cardiac remodeling and pharmacokinetic marker dynamics after acute decompensation in heart failure: insights from the BeLove study
Presentation
Genotype-dependent NT-proBNP, cardiac remodeling and pharmacokinetic marker dynamics after acute decompensation in heart failure: insights from the BeLove study
See more
Aortic regurgitation: links to declining hepatic-renal function, WWP-2 and IL-6 by genetic data
Presentation
Aortic regurgitation: links to declining hepatic-renal function, WWP-2 and IL-6 by genetic data
See more
Protease-activated receptor 2 (PAR2) inhibition reduces complement-associated cardiac remodelling in obesity-related heart failure
Presentation
Protease-activated receptor 2 (PAR2) inhibition reduces complement-associated cardiac remodelling in obesity-related heart failure
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources